Lv31
260 积分 2023-05-03 加入
Molecular mechanisms underlying nucleotide repeat expansion disorders
1个月前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
2个月前
已完结
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy
3个月前
已完结
† VERVE-102, a clinical stage in vivo base editing medicine, leads to potent and precise inactivation of PCSK9 in preclinical studies
4个月前
已完结
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
4个月前
已完结
To the Editor—Impact of mavacamten on atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy
4个月前
已完结
AMPLITUDE: A Phase 2/3 Adaptive Trial of Inaxaplin in APOL1-Mediated Kidney Disease
6个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
6个月前
已完结
Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
6个月前
已完结
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysis
6个月前
已完结
皖公网安备34019202002308
